Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

for
Advanced Solid Tumor
Location: Port Huron MI, Macomb MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT07098299

Phase 1, Recruiting

Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu

for
Metastatic Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07203378

Phase 2, Recruiting

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

for
Cancer, Oncology
Location: Hilo HI, Honolulu HI, Lihue HI
Sponsor: University of Hawaii

Sex: All

Age: 18+

Code: NCT06237816

Recruiting

Multi-center MRD Registry for Inflammatory Breast Cancer

for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06966050

Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: Boston MA, New Haven CT, Hackensack NJ, Philadelphia PA,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Behaviour Change for Cancer Survivors Trial

for
Cancer, Exercise
Location: Toronto
Sponsor: University of Toronto

Sex: All

Age: 18+

Code: NCT06624930

Recruiting

Precision Supplemental Imaging in Women With Dense Breasts

for
Breast Cancer, Cancer of the Breast
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 25 - 55

Code: NCT07277738

Recruiting

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07232043

Recruiting

Testing a WearabLE Artificial Intelligence-POwered Device For OPtimal DAily RaDiation Therapy Using Image Guidance

for
Pelvic Malignancies
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT06820385

Recruiting

ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging Devices

for
Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT01837225

Recruiting

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

for
Breast Cancer, Breast Carcinoma, Cancer of the Breast,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07619534

Recruiting

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

for
Hormone Receptor Positive Early Breast Cancer
Location: Margate FL, Port Orange FL, Beverly Hills CA
Sponsor: Rovi Pharmaceuticals Laboratories

Sex: Female

Age: 18 - 70+

Code: NCT07401381

Phase 1, Recruiting

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

for
Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor,
Location: Montreal, Toronto, Vancouver
Sponsor: Australian & New Zealand Children's Haematology/Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06208657

Phase 1, Phase 2, Recruiting

SAVE Trial: SAfe Opioid Use Video Education

for
Breast Reconstruction, Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Female

Age: 18+

Code: NCT07044583

Recruiting

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

for
Selected Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Glen Burnie MD
Sponsor: SK Life Science, Inc.

Sex: All

Age: 18+

Code: NCT07812805

Phase 1, Recruiting

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Lake Success NY, Fairfax VA, Nashville TN
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07730021

Phase 1, Phase 2, Recruiting

A Clinical Investigation of a Topical Moisturizer on Skin Barrier Function in Adults With Sensitive Skin

for
Sensitive Skin
Location: New York NY
Sponsor: Good Molecules, LLC

Sex: All

Age: 18 - 55

Code: NCT07811531

Recruiting

Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses

for
Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT05674825

Phase 1, Phase 2, Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: New York NY, Somerset NJ, Hampton VA, Baltimore MD,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New York NY, Houston TX
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT07408258

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial